Menarini Silicon Biosystems

Still time to register for the EACR webinar 'Circulating tumor cells analysis and characterization with CELLSEARCH®: reliable insights from the lab to the clinic' with Prof paola gazzaniga. In this webinar you will hear about the capabilities offered by the CELLSEARCH 4th open channel to characterize CTCs. Register now at https://lnkd.in/euSTDmfX European Association for Cancer Research (EACR) #freewebinar #CTC #CTCphenotyping #HER2 #CTCenumeration #AI #EACR

We are excited to be in Denver attending the 6th Annual Congress of Liquid Biopsy, ISLB. Stop by our booth to discover the most comprehensive solution for circulating tumor cells enumeration, biomarker phenotyping on CTCs and comprehensive genomic profiling with CELLSEARCH and MenariniSearch technologies. Discover how our clinical and global lab service offerings can provid you valuable insight into your patient's cancer journey and accelerate your clinical trial testing and research projects. Get in contact for more information and to meet our expert team! #ISLB #CTC #LiquidBiopsy

Join the MSB team at the Society of Neuro Oncology meeting in Houston, TX and learn how the MenariniSearch test can provide comprehensive insights from CerebroSpinal Fluid (CSF) for leptomeningeal disease and other CNS tumors! #CSF, #CNSTumors, #Leptomeningeal, #Brain, #MRI

Join Dr. Jennifer Davids on Nov 14th at 12pm EST for a Facebook Live Q&A on Circulating Tumor Cell Testing and Biomarker Monitoring with host Pink Ribbon Good! Follow their Facebook page for updates. #pinkribbongood #CTC #CellSearch #breastcancer https://lnkd.in/ehAFsPjy

We are excited to be in Lyon attending the EACR Liquid Biopsy Congress.  Don't miss the presentation "Technologies for cell-based liquid biopsy" on Wednesday 13 November at 8:45 am. Come to meet us! #EACR #LiquidBiopsy #MultipleMyeloma #CTC #Technologies

📢 We are hiring! We are looking for a Quality Analyst to join our team in Huntingdon Valley! w Check out the full job description! https://lnkd.in/eqnEvrdT #hiring #jobopening #Menarini

Save the date: 5 December 2024, 3 pm CET! We are hosting a free webinar together with European Association for Cancer Research (EACR) titled 'Circulating tumor cells analysis and characterization with CELLSEARCH®: Reliable insights from the lab to the clinic'. Professor paola gazzaniga from Sapienza University in Rome will share her experience using the CELLSEARCH open fluorescent channel for CTC phenotyping. Register now: https://lnkd.in/euSTDmfX #freewebinar #CTC #CTCphenotyping #HER2 #CTCenumeration #AI #EACR

While Circulating Tumor Cells (CTCs) in metastatic breast cancer continue to be a strong marker of prognosis, evidence has documented that CTCs in patients with HER2-negative primary tumors can evolve to be HER2-positive, thus emphasizing the need to periodically monitor HER2 beyond the primary tumor. The CELLSEARCH CTC Enumeration test with HER2 phenotyping measures HER2 protein expression of CTCs alongside our gold-standard enumeration assay. In the US, the test is available for physicians as a Laboratory-Developed Test (LDTs)* for patient management or for biopharma and clinical trials research as a CLIA-certified test. #LDT #HER2 #Biomarker #LiquidBiopsy *The CELLSEARCH® CTC Enumeration with HER2 test has not been cleared or approved by the FDA. In the U.S. it is only available as a commercial, CLIA-approved assay that meets the certification standards of The Centers for Medicare and Medicaid Services. https://lnkd.in/dPGqv26W

Twisted Pink will be hosting a Lunch and Learn on Nov 7th at 7pm EST on Circulating Tumor Cell Testing and Biomarker Monitoring with Dr. Jennifer Davids. Register here and join the discussion! https://lnkd.in/dyWVGnPd #twistedpink #CTC #biomarker #breastcancer

November is lung cancer awareness month, a time to bring attention to a disease responsible for the most cancer-related deaths globally. This November, we at Menarini Silicon Biosystems honor those working to reduce frequency and expand treatment options for lung cancers, those treating #NSCLC and #SCLC, and those that have battled lung cancers. #lungcancerawareness